Device of Tomorrow Capital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Lazzaro Medical develops a minimally invasive robotic surgery for repairing tracheobronchomalacia (TBM), a degenerative airway disease, using an implantable scaffold system as an alternative to risky open surgery.
BiotechHealthtechMedical DevicesRoboticsBoulder, US
Richard S. Lazzaro, M.D.(Director, Executive Officer, Promoter)inD. Dawn Bitz(Ms. Bitz is the President of the Issuer.)inRobert J. Wiesenberg(Mr. Wiesenberg is the Chief Operating Officer of the Issuer.)inRyan G. Redford(Mr. Redford is the Chief Technology Officer of the Issuer.)Frederick J. Onorato(Mr. Onorato is the Secretary of the Issuer.)inJames R. Polsen(Executive Officer)in
Co-investorsColorado BioScience Association
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




